clinical trial · NCT03971422
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
UCB Biopharma SRL·phase3·completed·n = 200
Generalized Myasthenia GravisRozanolixizumabPlacebo
brief summary
The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG).
started
Jun 3, 2019
primary completion
Aug 31, 2021
completion
Oct 26, 2021
last updated
Dec 24, 2025
official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol